azacrin has been researched along with pyrimethamine in 1 studies
Studies (azacrin) | Trials (azacrin) | Recent Studies (post-2010) (azacrin) | Studies (pyrimethamine) | Trials (pyrimethamine) | Recent Studies (post-2010) (pyrimethamine) |
---|---|---|---|---|---|
6 | 0 | 0 | 5,088 | 738 | 1,047 |
Protein | Taxonomy | azacrin (IC50) | pyrimethamine (IC50) |
---|---|---|---|
Dihydrofolate reductase | Homo sapiens (human) | 3.1057 | |
Dihydrofolate reductase | Bos taurus (cattle) | 0.1007 | |
Beta-hexosaminidase subunit alpha | Homo sapiens (human) | 6.8333 | |
Beta-hexosaminidase subunit beta | Homo sapiens (human) | 6.4 | |
Dihydrofolate reductase | Escherichia coli K-12 | 4.3 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.0609 | |
Dihydrofolate reductase | Pneumocystis carinii | 3.25 | |
Dihydrofolate reductase | Candida albicans | 5 | |
Low molecular weight phosphotyrosine protein phosphatase | Homo sapiens (human) | 15.615 | |
Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.39 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.3217 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum 3D7 | 2.48 | |
Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 2.0727 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
1 other study(ies) available for azacrin and pyrimethamine
Article | Year |
---|---|
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |